These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9435408)

  • 1. Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles.
    Baker VL; Draper M; Paul S; Allerheiligen S; Glant M; Shifren J; Jaffe RB
    J Clin Endocrinol Metab; 1998 Jan; 83(1):6-13. PubMed ID: 9435408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intranasal administration of norethisterone on folliculogenesis, cervical mucus, vaginal cytology, endometrial morphology and reproductive-endocrine profile in women.
    Kumar TC; Shah RS; Chitlange SM; Hazari KT; Gopalkrishnan K; Vadigoppula AD; Vernekar VJ; Borkar DM; Puri CP
    Contraception; 1991 Sep; 44(3):245-67. PubMed ID: 1764942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
    Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
    J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
    Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
    Sherman BM; Chapler FK; Crickard K; Wycoff D
    J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of luteal phase estrogen antagonism on endometrial development and luteal function in women.
    Fritz MA; Westfahl PK; Graham RL
    J Clin Endocrinol Metab; 1987 Nov; 65(5):1006-13. PubMed ID: 3667871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective modulation of estrogen receptor action.
    Sadovsky Y; Adler S
    J Clin Endocrinol Metab; 1998 Jan; 83(1):3-5. PubMed ID: 9435407
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins.
    de Ziegler D; Bergeron C; Cornel C; Medalie DA; Massai MR; Milgrom E; Frydman R; Bouchard P
    J Clin Endocrinol Metab; 1992 Feb; 74(2):322-31. PubMed ID: 1730810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired folliculogenesis and ovulation in older reproductive aged women.
    Santoro N; Isaac B; Neal-Perry G; Adel T; Weingart L; Nussbaum A; Thakur S; Jinnai H; Khosla N; Barad D
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5502-9. PubMed ID: 14602797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programming ovulation in the menstrual cycle by a simple innovative approach: back to the future of assisted reproduction.
    de Ziegler D; Brioschi PA; Benchaa C; Campana A; Ditesheim PJ; Fanchin R; Bulletti C
    Fertil Steril; 1999 Jul; 72(1):77-82. PubMed ID: 10428152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics.
    Bergemann N; Mundt C; Parzer P; Jannakos I; Nagl I; Salbach B; Klinga K; Runnebaum B; Resch F
    Schizophr Res; 2005 Mar; 73(2-3):357-66. PubMed ID: 15653282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
    Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.